News 2025
16.04.2025
Focus on tuberculosis: Interdisciplinary workshop at the FZB with participants from all over Europe
From 31.3-12.4.2025 the 14-day course “Interdisciplinary training in genomic epidemiology and public health bioinformatics (5th Edition TB)” took place at the Research Center Borstel, Leibniz Lung Center.
14.04.2025
Award for the best medical case report of the year. Borstel doctoral student honored at the DGP annual conference in Leipzig
Johanna Eggeling, a doctoral student in the Clinical Infectious Diseases group at the Research Center Borstel, has received the award for the best medical case report at the 2025 annual conference of the German Society of Pneumology (DGP) in Leipzig. The award is given in recognition of an outstanding individual case presentation in the journal Pneumologie that combines medical findings with social relevance.
03.04.2025
New test improves tuberculosis diagnosis in adults living with HIV
A molecular stool test, previously used primarily in children, is showing promising results for the diagnosis of tuberculosis in HIV-positive adults. This is the key finding of the international stool4TB study, conducted in Mozambique, Uganda, and Eswatini, with participation from the Research Center Borstel.
25.03.2025
Successful 2nd Edition of the “Bacterial Genome Sequencing Pan-European Network Conference” in Engelberg, Switzerland
A coalition of leading tuberculosis (TB) experts and medical societies is calling for an urgent expansion of the European Medicines Agency (EMA) label for pretomanid, a key drug in the fight against multidrug-resistant tuberculosis (MDR-TB) and rifampicin-resistant TB (RR-TB). This appeal aligns with the latest World Health Organization (WHO) guidelines and aims to improve patient access to more effective and tolerable treatment regimens.
18.03.2025
Tuberculosis trends in Europe: Rising drug-resistant cases demand urgent action
A team of researchers from the Research Center Borstel in Germany, Imperial College London in the UK, and the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden, has analyzed tuberculosis notification rates across the European Union/European Economic Area (EU/EEA) from 2019 to 2023.